National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

anti-EpCAM-Pseudomonas-exotoxin fusion protein (...SOO-doh-MOH-nus-EK-soh-TOK-sin FYOO-zhun PROH-teen)

 A substance being studied in the treatment of certain types of head and neck cancer. Anti-EpCAM-Pseudomonas-exotoxin fusion protein is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. It binds to EpCAM (a protein on the surface of epithelial cells and some types of cancer cells). Also called Proxinium and VB4-845.



Previous Definitions:anti-CD19 immunotoxin, anti-CD22 immunotoxin, anti-CD22 immunotoxin CAT-8015, anti-CD45 monoclonal antibody, anti-CEA antibody
Next Definitions:anti-idiotype vaccine, anti-IL-6 chimeric monoclonal antibody, anti-inflammatory, anti-mesothelin monoclonal antibody MORAb-009, anti-TGF-beta monoclonal antibody GC1008

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov